eREX Co.,Ltd.
eREX Co.,Ltd. (9517.T) Financial Performance & Income Statement Overview
Explore the financials of eREX Co.,Ltd. (9517.T), including yearly and quarterly data on income, cash flow, and balance sheets.
eREX Co.,Ltd. (9517.T) Income Statement & Financial Overview
View the income breakdown for eREX Co.,Ltd. 9517.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $44.63B | $43.37B | $49.77B | $33.44B |
| Cost of Revenue | $39.59B | $37.90B | $43.80B | $29.42B |
| Gross Profit | $5.05B | $5.47B | $5.97B | $4.02B |
| Gross Profit Ratio | $0.11 | $0.13 | $0.12 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.97B | $3.12B | $2.66B | $2.15B |
| Operating Expenses | $2.97B | $2.65B | $2.66B | $2.15B |
| Total Costs & Expenses | $42.55B | $40.55B | $46.46B | $31.57B |
| Interest Income | $0.00 | $540.00M | $0.00 | $1.51B |
| Interest Expense | $642.00M | -$391.00M | $629.00M | $240.00M |
| Depreciation & Amortization | $915.00M | $979.00M | $907.00M | $908.00M |
| EBITDA | $43.00M | $3.36B | $4.14B | $2.89B |
| EBITDA Ratio | $0.001 | $0.08 | $0.08 | $0.09 |
| Operating Income | $2.08B | $2.82B | $3.32B | $1.87B |
| Operating Income Ratio | $0.05 | $0.07 | $0.07 | $0.06 |
| Other Income/Expenses (Net) | -$3.84B | $974.00M | -$2.11B | $1.27B |
| Income Before Tax | -$1.76B | $3.80B | $1.21B | $3.14B |
| Income Before Tax Ratio | -$0.04 | $0.09 | $0.02 | $0.09 |
| Income Tax Expense | $437.00M | $733.00M | $577.00M | $831.00M |
| Net Income | -$2.30B | $2.73B | -$60.00M | $1.75B |
| Net Income Ratio | -$0.05 | $0.06 | -$0.001 | $0.05 |
| EPS | $29.62 | $36.74 | -$0.81 | $25.22 |
| Diluted EPS | $29.62 | $36.74 | -$0.81 | $25.22 |
| Weighted Avg Shares Outstanding | $74.28M | $74.28M | $74.26M | $69.28M |
| Weighted Avg Shares Outstanding (Diluted) | $74.28M | $74.28M | $74.26M | $69.28M |
Financial performance has remained strong, with revenue growing from $33.44B in Q1 2024 to $44.63B in Q4 2024. Gross profit continued to perform well, with margins at 11% in the latest quarter. Operating income reached $2.08B in Q4 2024, holding a steady 5% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $43.00M. Net income dropped to -$2.30B, keeping EPS at $29.62. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan